CDKN1B and hepatocellular carcinoma: This post-translational modification enhances SKP2 stability and E3 ligase activity, promoting p21/p27 degradation and accelerating the G1-S phase transition, thereby driving hepatocellular carcinoma (HCC) cell proliferation (Feng et al., 2024).